Global pharma major Lupin Limited launches its Regional Reference Laboratory in Indore, Madhya Pradesh, as part of its expansion in Central India.
Lupin Diagnostics currently operates 325+ LupiMitra (Lupin’s franchise collection centers) and 23 laboratories in India.
As per the filing, the expansion in Indore is well-aligned with Lupin Diagnostics’ commitment to improving access to high-quality, reliable, and advanced testing centres and home collection facilities at an affordable price.
In addition to routine and specialized tests, Lupin Diagnostics also offers molecular diagnostics, cytogenetics, flow cytometry, cytology, microbiology, serology, hematology, immunology, routine biochemistry and many more. The labs are equipped with professional and qualified clinical experts and automated, streamlined processes so patients can make informed decisions about their health.
Commenting on the launch, Ravindra Kumar, CEO – Lupin Diagnostics said, “The launch of our bestin-class regional reference lab in Indore marks our expansion into Central India. With this lab and collection centres in the region, we take the responsibility to provide superior pathology tests, curated health check packages and molecular diagnostics advanced testing facilities.”
At around 9:36 AM, Lupin was trading at Rs758.90 per share higher by 1.02% on the BSE.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.